Homocysteine and vascular access thrombosis in end-stage renal disease patients: A retrospective study

Journal of Nephrology

Volumn 15, Issue 6, 2002, Pages 666-670

  Bowden, Rodney G ^a   Wyatt, Frank B ^a   Wilson, Ronald ^b  

^a BAYLOR UNIVERSITY   (United States)

^b Brazos Kidney Center   (United States)

Author keywords

Clotted access; Total homocysteine; Vascular access thrombosis

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; GENDER; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KOLMOGOROV SMIRNOV TEST; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PATIENT SELECTION; PROSPECTIVE STUDY; RANK SUM TEST; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THROMBOSIS; VARIANCE; VASCULAR ACCESS;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATHETERS, INDWELLING; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROBABILITY; RECURRENCE; REFERENCE VALUES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; THROMBOSIS;

EID: 0036868186     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tamura T, Bergman SM, Morgan SL. Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 1998; 32: 475-81.
2. Shemin D, Lapane KL, Bausserman L, Kanaan E, Kahn S, Dworkin L, Bostom A. Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. J Am Soc Nephrol 1999; 10: 1095-9.
3. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-6.
4. Manns BJ, Burgess ED, Parsons HG, Schaefer JP, Hyndman ME, Scott-Douglas NW. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 1999; 55: 315-20.
5. Finkelstein JD. Regulation of homocysteine metabolism. In: Carmel R, Jacobsen DW eds. Homocysteine in Health and Disease. New York: Cambridge University Press 2001; 92-9.
6. Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME. Prophylaxis of hemodialysis graft thrombosis with fish oil; Double-blind, randomized, prospective trial. J Am Soc Nephrol 2002; 13: 184-90.
7. Lentz SR. Homocysteine and cardiovascular physiology. New York: Cambridge University Press, 2001; 441-50.
8. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 2002; 61: 609-14.
9. Ducloux D, Pascal B, Jamali M, Gibey R, Chalopin JM. Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients? Nephrol Dial Transplant 1997; 12: 2037-8.
10. Sirrs S, Duncan L, Ognjenka D, Nussbaumer G, Ganz G, Frohlich J, Levin A. Homocyst(e)ine and vascular access complications in haemodialysis patients: Insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738-43.
11. Fermo I, D'Angelo SV, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Am J Kidney Dis 1995; 22: 215-25.
12. Van Heijer M, Koster T, Blom HJ, Gerritis WB, Rosendaal FR, Haak HL, Wijermans PW, Bos GM. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
13. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-57.
14. Ridker PM, Henneckens CH, Selhub J, Miletich JP, Mlnow MR, Stampfer MJ. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997; 95: 1777-82.
15. Kes P. Hyperhomocysteinemia in end-stage renal failure. Acta Med Croat 2000; 53: 175-81.
16. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-8.
17. Quéré I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daurès JP, Schved JF, Mercier E, Laroche JP, Dauzat M, Bounameaux H, Janbon C, De Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: A matched case-control study. Lancet 2002; 359: 747-52.